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INTRODUCTION
Periodontal disease is one of the most common pathogenic conditions to affect the
human oral cavity [1]. Its most common form, chronic periodontitis, is caused by a
bacterial-induced chr()nic inflammatory reaction, which ultimately destroys the
attachment apparatus of the dentition [2]. As a supragingival biofilm, largely composed
of Gram-positive aerobic microorganisms, accumulates apically along the tooth surface, a
new ecological niche is created enabling the predominately Gram-negative anaerobic
flora commonly found in periodontal pockets to thrive [3]. Specific bacteria cultllred
from periodontal pockets have been described as more pathogenic than others, namely
Actinobacillus actinomycetemcomitans, Prevotella intermedia, Tannerellaforsythensis,
Porphyromonas gingivalis, and 1"reponema denticola [4, 5], and have been shown to
adversely affect the outcome of periodontal therapy [6]. In fact, P. gingivalis, known to
be one of the most pathogeIlic microorganisms recovered in the gingival crevice, can be
isolated in high numbers and prevalence in patients with chronic and aggressive forms of
periodontitis. By contrast, periodontally healthy patients will have either no P. gingivalis
or only small quantities in subgingival plaque. A shift in bacterial flora to include these
organisms is associated with an increase in the inflammatory cell infiltrate within the
gingival epithelium and connective tissue, leading to a release of inflammatory mediators
including interleukin-l B(IL-l B), interleukin-6 (IL-6), interleukin-8 (IL-8), tumor
necrosis factor-a (TNF-a), prostaglandin E2 (PGE2), and matrix metalloproteinases
(MMPs), which recruit lymphocytes, fibroblasts, and osteoclasts that degrade the
surrounding periodontal tissues.
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2The subgingivallnicroflora at destructive inflammatory disease sites elicits the
complex host immune response through virulence factors such as endotoxin, lipoproteins,
proteases, and lipopolysaccharide (LPS). Of these, the most studied by far has been LPS,
which is a cell wall constituent of Gram-negative microorganisms. Although evidence for
the penetration of LPS into gingival tissue has been reported [7, 8], its location in these
tissues at human disease sites is questionable. It has been demonstrated, however, that
entire bacteria, including P. gingivalis, can penetrate the connective tissue through micro-
ulcerations within pocket epithelium, thus contaminating these tissues with LPS [9, 10].
This, though, does not appear to be the main mode for the destruction of the
periodontium since the invasive bacterial counts are minimal [11]. Instead, many
periodontal pathogenic microorganisms bind to pocket epithelial cells, exposing these
and neighboring host inflamrrlatory cells to LPS and other virulence factors. Bacterial
lipopolysaccharide acts by binding to tIle LPS-binding protein (LBP), a plasma protein
[121. The LPS-LBP complex then binds to both soluble and menlbrane-bound CD-14 on
peripheral blood monocytes, nlacrophages, or vascular endothelial cells, resulting in
intracellular signaling to upregulate cytokine gene transcription. In fact, Schumann and
coworkers reported that the l"PS-LBP complex is 1,OOO-foid more active than LPS itself
in stinlulating TNF-a synthesis froIn macrophages [13]. However, a later study indicated
that blocking the CD-14 receptor with antibodies had- no effect on the TNF-a production
if the LPS concentrations were sufficiently high, indicating that other receptors may be
involved [14].
Recently, researchers have identified a family of evolutionarily conserved
microbial pattern-recognition receptors known as Toll-like receptors (TLRs). Receptors
3in this family have an intracellular domain which shares homology with the IL-l
receptor. Activation of TLRs initiates a signal transduction cascade leading to the
activation of nuclear factor-kappa B (NF-KB) and eventual production of the pro-
inflammatory cytokines TNF-a, IL-l, IL-6, and IL-8 [15]. It appears that most Gram-
negative LPS binds to TLR-4 [16,17], although conflicting data have demonstrated that
P. gingivalis LPS may also bind to TLR-2 [18, 19]. Thus, LPS can either directly or
indirectly induce the secretion of pro-inflammatory mediators from surrounding
peripheral blood monocytes, macrophages, and other host cells. These mediators then
amplify the inflammatory cytokine cascade leading to the destnlction of the periodontal
attachment apparatus.
Of all the known periodontal pathogens, Porphyromonas gingivalis, an
obligately-anaerobic Gram-negative asaccharolytic coccobacillus, seems to be one of the
most vilulent. Its prominence is related to the expression of many phenotypic factors
including firrlbrial adhesins, LPS, collagenase, and trypsin-like enzymes. Recently,
researchers ha-ve discovered two fimbrillin proteins, one 41-kDa and the other 67-kDa, on
the P. gingivalis cell surface which were shown to aid in the adherence to gingival
epithelial cells [20]. Furthermore, P. gingivalis produces cysteine endopepdidases known
as gingipains which account for 85% of the general proteolytic activity and 100% of the
trypsin-like activity of this periodontal pathogen [21]. Gingipain K releases bradykinin
from hIgh molecular weight kininogen, and has strong fibrinolytic activity which may
contribute to clinical bleeding on probing in patients with periodontitis. Gingipain R
activates thrombin pro'duction, which has pro-inflammatory actions, and degrades C3, a
complement protein whose cleavage results in opsonization and neutrophil chemotaxis.
4Furthermore, both gingipains inactivate IL-8, another potent nelltrophil chemoattractant.
More importantly, these enzymes degrade macrophage CD-14, thereby inhibiting the
activation of leukocytes through the LPS receptor. Such a finding is corroborated by the
fact that P. gingivalis LPS is not as potent a stimulator of PGE2 secretion from human
monocytes in vitro when compared with other suspected periodontal pathogens [22]. All
of these factors can modulate bacterial capacities for cellular attachment, invasion, or
destruction.
The lipopolysaccharide molecule contains three structural components: an 0-
specific polysaccharide, a core polysaccharide, and Lipid A. It has been demonstrated
that the Lipid A portion of the molecule is responsible for inflammatory cell activation,
and its potency differs among bacterial species [23]. Covalently bonded to Lipid A by
either amide or ester linkages are even carbon-chain 2-hydroxy and odd-chain
isobranched 3-hydroxy fatty acids. Interestingly, these fatty acids are also found linked to
long-chain bases, forming complex lipids of the sphingolipid class called ceramides [24.].
Periodontal pathogenic microorganisms of the Bacteroides, Porphyromonas, and
Prevotella genera synthesize several hydroxy fatty acids, one of which is 3-hydroxy-15-
methylhexadecanoate (3-0H iSOC 17:0) [25]. The predominant hydroxy fatty acid of most
Gram-negative bacteria is 3-0H C14:0 , but more than 50% of the fatty acid of P.
gingivalis is 3-0H iSOC 17:0 [26]. Furthermore, even though mammalian cells have not
been shown to produce 3-0H iSOC17:0, this fatty acid has been recovered in lipid extracts
of periodontally diseased human cementum and gingival tissues [27J. Additionally, it is
now established that most of the sphingolipid recovered from P. gingivalis are free and
phosphorylated dihydroceramides, which include 3-0H iSOC 17:0 in amide linkage to long-
5chain bases of 17, 18, and 19 carbons in length [28]. These specific ceramide lipids of P.
gingivalis are biologically active, promoting a markedly greater secretion of PGE2 from
IL-1 ~-treated gingival fibroblasts than is observed with IL-1 ~ alone [29].
Since these bacterial ceramides, some of which contain 3-0H iSOC17 :0, but not
LPS, are virtually insoluble in aqueous solution, a novel mechanism of bacterial lipid
deposition and systemic infiltration has been proposed by Nichols [27]. Although the
bacterial hydroxy fatty acids may be separated from the Lipid A portion of LPS and
retained in the gingival tissues, these fatty acids would not be expected to link to
saturated long-chain bases as is observed in ceramides of P. gingivalis. Stated another
way, recovery of bacterial ceramides in diseased human tissue samples is not likely to
represent breakdown of P. gingivalis LPS and subsequent incorporation of bacterial fatty
acid into host sphingolipids. Additionally, because 3-0H iSOC17 :0 is not recovered in
plasma fronl patients with periodontitis, it is unlikely that P. gingivalis lipids are taken up
and carried freely in this medium~ Instead, since 3-0H iSOC17 :0 is recovered in circulating
blood cells in patients with periodontitis, it is possible that P. gingivalis lipids are
incorporated into cell membranes of circulating blood cells, particularly phagocytes. In
fact, there is evidence suggesting that P. gingivalis sheds outer membrane vesicles in
culture medium during growth [30]. Other research has shown that human gingival
fibroblasts [29] and peripheral blood monocytes (Nichols, unpublished data) take up such
complex lipids of P. gingivalis as evidenced by the facile incorporation of these lipids
when cells are plated on culture surfaces coated with bacterial lipid. Assuming the same
is true in blood, the frequent bacteremias associated with periodontal disease [31, 32]
would be expected to contaminate circulating blood cells with these biologically active
6lipids. Furthermore, the attachment of P. gingivalis to junctional and sulcular epithelial
cells [33] or its invasion into periodontal connective tissue [34] cOllld also provide a
source of bacterial lipid to surrounding host inflammatory cells. Thus, monocytes and
macrophages at the infected periodontium could incorporate the lipids into their own cell
membranes and deliver them to other tissues, including arterial walls susceptible to
atherosclerosis.
Atherosclerosis pathogenesis
Atherosclerosis is the most common form of arteriosclerosis, which refers to the
thickening of vessel walls [35]. It is a pathologic process which has beCOITle the leading
cause of human vascular disorders including coronary artery disease (CAD),
cerebrovascular disease, and diseases of the aorta and peripheral arterial circulation.
These vascular diseases are responsible for more deaths than an)' other disease in
humans. The hallrrlark of the atherosclerotic lesion is the accumulation of lipid within the
vessel wall and subsequent fibrosis and calcification of the connective tissue, which
eventually obstructs blood flow through the lumen, predisposes the vessel to thrombosis,
and weakens its elasticity in response to hydrodynamic stresses. Although there have
been numerous risk factors attributed to the cause of atherosclerosis such as hypertension,
diabetes mellitus, cigarette smoking, increased age, physical inactivity,
hyperhomocystinemia, hypercoagulability, and angiotensin-converting enzyme
polymorphisms, hyperlipidemia seems to be the most studied factor. However, like
7periodontal disease, atherosclerosis is considered to be a chronic inflammatory disease,
sharing similar inflammatory and immunological mediators [36].
Histologically, blood vessel walls are composed of three distinct layers: the tunica
intima, tllnica media, and tunica adventitia [37]. The innermost layer, the tunica intima,
contains a single layer of squamous epithelial cells, called endothelium, which rests on a
basal lamina. The subendothelial connective tissue may contain smooth muscle cells,
sporadic macrophages and lymphocytes, and, in arteries, a layer of fenestrated elastic
tissue known as the internal elastic lamina. The tunica media is largely composed of
circllmferential1y arranged smooth muscle cells with interposed elastin, reticular fibers,
and proteoglycans. It extends from the internal elastic lamina to the external elastic
lamina, which is a thin layer of elastin separating the tunica media from the tunica
adventitia. This third layer is composed mostly of collagen, microvasculature,
lymphatics, and loose connective tissue surrounding the vessel.
Arteries are distinguished from one another by the thickness and composition of
the various layers; and are categorized by size into large (elastic) arteries, medium
(muscular) arteries, small arteries, and arterioles. The large arteries such as the aorta and
pulmonary arteries are extremely elastic to accommodate the high blood pressure
generated by contraction of the ventricles. Thus, the tunica media is the thickest layer in
these arteries consisting of concentric layers of elastin and sheets of smooth muscle cells.
The intima is also relatively thick with an inconspicuous internal elastic lamina. Medium
sized arteries have much more smooth muscle and less elastin in the tunica media than
large arteries. These arteries are thus more apt to contract, aiding in the regulation of
blood pressure. Furthermore, they have a more distinct internal elastic lamina and a
8thicker tunica adventitia. By contrast, small arteries and arterioles have only 1-8 layers of
smooth muscle cells in their tunica media, a thin tunica intima, and a tunica adventitia
which blends into the surrounding connective tissue.
Atherosclerosis occurs mainly in large and medium sized arteries. In humans, the
most commonly affected vessels are the abdominal aorta, coronary arteries, aortic arch,
descending thoracic aorta, internal carotids, femoral and iliac arteries, and the Circle of
Willis. However, the location of occurrence varies in other animal species. Evidence
suggests that the majority of lesions are associated with branch points or areas of low
shear stress [38]. Although controversial, the earliest sign of atherosclerosis is intimal
thickening, in which a layer of connective tissue separates the endothelium from the
internal elastic lamina. Some argue that this finding may be an adaptive response to
normal vessel stress, but most agree that these sites are most likely to develop
atherosclerosis. It is at these lesion-prone sites that lipid will most commonly accumulate
in arterial walls.
The American Heart Association has recently defined six stages of atherosclerotic
lesion development [39, 40]. The type I lesion is defined as the first microscopically and
chemically detectable lipid deposits not visible to the naked eye. The type II lesion is
known as the fatty streak, which is a small yellow lump in the vessel wall consisting of
lipid-laden macrophages and smooth muscle cells known as foam cells. Much of the lipid
at this stage is intracellular. The type III lesion represents a transitional stage between
fatty streaks and advanced lesions. The hallmark of this stage is multiple extracellular
lipid pools which do not have a clearly delineated acellular lipid core. Type IV lesions
have this well-defined acellular lipid core usually at the deepest portion of the tunica
9intima. This core is largely composed of cholesterol esters and cholesterol, as well as
necrotic foam cells. Calcifications mostly composed of apatite crystals are also found at
the musculoelastic junction. Once smooth muscle cells are found surrounding the core
flanked by groups of macrophages and lymphocytes (known as a fibrous cap), the type V
lesion is established. Finally, the type VI lesion is marked by loss of surface integrity,
ulceration, hematoma formation, and eventual thrombus formation.
The atherogenic process is initiated by a mechanical or biochemical injury to the
arterial endothelium, enabling increased adherence of peripheral blood monocytes and
platelets, and enhanced permeability of monocytes, macrophages, and lipoproteins into
the intima. Both ingested and endogenously synthesized cholesterol is transported to and
from the liver by lipoproteins in the plasma and lymph. One specific lipoprotein, low-
density lipoprotein (LDL), carries most cholesterol in the form of cholesterol esters. LDL
and other lipoproteins, such as very low--density lipoprotein (VLDL), accumulate as a
result of either high-lipid dietary intake or increased hepatic cholesterol synthesis. Free-
radical oxidative metabolites of endothelial cells and monocytes then initiate lipid
oxidation within the-lipoproteins. The resulting oxidized LDL (oxLDL) has been shown
to up-regulate adhesive proteins such as vascular cell adhesion molecule-l (VCAM-I),
intercellular adhesion molecule-l (ICAM-1), E-selectin, and monocyte chemotactic
protein-l (MCP-I) [41], which aid in the adhesion, rolling, and diapedesis of leukocytes.
It should be emphasized that elevated expression of these adhesion molecules is also
promoted by inflammatory cytokines such as IL-l ~ and TNF-a. In conjunction with
these proteiJ)s, oxLDL exacerbates the endothelial dysfunction by oxidatively modifying
cell membrane phospholipids, allowing greater adherence and influx of inflammatory
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cells into the intima. Furthermore, the excessive production of superoxide anions
decreases the bioavailability of nitric oxide (NO), which normally protects the
endothelium by inducing vasodilation, inhibiting platelet aggregation and smooth muscle
cell proliferation, and blocking endothelial-leukocyte interactions. Additionally, oxLDL
enables endothelial cells to express macrophage colony stimulating factor (M-CSF),
which stimulates the conversion of monocytes to macrophages in the tunica intima [42],
initiating fatty streak formation.
There are several checks produced by the host that play key roles in inhibiting the
atherogenic process. The first resides in the control of MMP activity. Although MMPs
can be inhibited by plasma <X2-macroglobulin, the tissue inhibitors of metalloproteinases
(TIMPs) are the major inhibitory proteins in the connective tissue. TIMPs have complex
three-dimensional structures defined by six disulfide bridges creating six loops. The first
three loops form high-affinity non-covalent complexes with the propeptide portion of
active metalloproteinases, inhibiting their activity. However, the exuberant MMP
response to inflammatory cytokines ultimately exceeds TIMP activity, contributing to
tissue breakdown. As a second check, high-density lipoprotein (HDL) has been shown to
inhibit the oxidation of LDL via two enzymes: platelet-activating factor acetylhydrolase
and paraoxonase [43]. HDL has also been shown to hamper the cytokine-induced
expression of endothelial cell adhesion molecules, thereby reducing the quantity of
monocyte immigration [44]. Finally, excess oxLDL in the intima is internalized by
monocytes and macrophages by binding to their acetyl LDL- and oxidized LDL-receptors
[4·5] such as the scavenger receptors CD-36 and CD-68, and LOX-l [46]. Under normal
concentrations of serum LDL, the phagocytic cells degrade oxLDL, ridding arteries of
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this inflammatory mediator. However, with elevated serum oxLDL, this scavenger
system becomes overburdened, and cholesterol esters accumulate both intra- and extra-
cellularly. With the net increase of oxLDL in the intima, endothelial damage occurs and
the atheroma lesion precipitates.
As macrophages accumulate within the arterial intima, they take up oxLDL in
both cytosolic and lysosomal compartments and are transformed into foam cells [47]. In
addition, the decrease of endothelially produced NO promotes proliferation of smooth
muscle cells (SMCs) from the tunica media to the intima. If the combination of
hyperlipidemia, monocyte adhesion, subendothelial migration of SMCs, and foam cell
formation persist, type II lesions (fatty streaks) will be apparent. Interestingly, recent
evidence suggests that P. gingivalis may stimulate foam cell formation by promoting
LDL binding to macrophages and LDL aggregation [48, 49]~ Next, T lymphocytes are
recruited, which release cytokines signaling macrophages to release MMPs and other
proteases, which remodel the extracellular matrix. It has been suggested that MMP
activity provides more substrate for heparinase (secreted by macrophages), which may
playa role in SMC phenotype modulation [50], upregulating scavenger receptors and
increasing lipid accllnlulation. As the progression continues, platelets aggregate at the
dysfunctional endothelium and, along with SMCs, secrete growth factors such as platelet-
derived growth factor (PDGF), fibroblast growth factor (FGF), and transforming growth
factor-a (TGF-a), mediating cell migration, proliferation, extracellular matrix deposition,
and further unwanted gene expression [43]. In fact, it has been shown that some of the
proteoglycans have an increased capacity to bind LDL. The atherosclerotic lesion at this
12
stage consists of an aggregation of foam cells and extracellular lipid surrounded by SMCs
and fibrous tissue consistent with the type III lesion, a fibrous plaque.
Sometimes, atheromas undergo considerable connective tissue formation with
little central lipid accumulation. Usually, however, the lipid-laden macrophage foam cells
eventually show signs of cell death or disintegration, creating a necrotic core in the
fibrous plaque typical of the type IV lesion. At this stage, much of the intracellular
cholesterol has crystallized. As the lesion increases in size and more SMCs migrate to the
plaque, the fibrofatty atheroma becomes the type V lesion. As stated earlier, type VI
atherosclerosis consists of ruptllre and ulceration of the endothelium leading to
intraplaque hemorrhage and thrombus formation. However, it appears that type IV and V
lesions are just as prone to rupture due to the "shoulders" of macrophages and T
lymphocytes along the fibrous cap [51]. These areas tend to be the most unstable,
especially when there is a paucity of smooth muscle cells and collagen to contain these
clusters. The MMPs produced by macrophage-derived foam cells will further aid in the
matrix degradation causing plaque rupture. Thus, the vulnerability of the atheroma
depends more on the plaque composition (lipid rich/collagen poor) rather than plaque
volume (severity of stenosis). The clinical outcome depends on the location, severity, and
duration of the ischemia caused by the occlusion. This can range from differing stages of
angina to infarction and stroke.
Murine models of atherosclerosis
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Since the study of atherosclerotic plaques in humans has many technical and
ethical considerations, the use of animal models has become an acceptable substitute.
Recent experiments have used mice, rats, rabbits, hamsters, guinea pigs, chickens, swine,
dogs, cats, and monkeys. In general, mice are highly resistant to atherosclerosis. In fact,
when fed a low-fat, low-cholesterol diet, they typically have cholesterol levels less than
100 mg/dl, mostly contained in HDL, and do not develop atherosclerotic lesions.
Furthermore, wild-type mice generally do not develop significant atherosclerosis when
fed high-fat diets.
Of particll1ar interest in current cardiovascular research, inbred, transgenic, and
gene-targeted mice are used for advantageous reasons. Transgenic mice are those in
which specific genes, which are involved in the regulation of lipoprotein metabolism, are
overexpressed. For instance, gene-targeted mice such as those homozygous deficient for
apolipoprotein E (apoE) will spontaneously develop fatty streaks progressing to fibrous
plaques on a normal diet with cholesterol levels ranging from 400-600 mg/dl; and more
expansive lesions on a high-cholesterol diet with cholesterol levels at 1500-2000 mg/dl
[52]. Apolipoprotein E is a 34kD glycoprotein component of lipoproteins that is
synthesized in the liver, brain, and other tissues. It has been shown to interact with
apolipoprotein B-48 and chylomicron remnant receptors to aid in the hepatic metabolism
of various apoE-containing lipoproteins such as VLDL and chylomicrons. As another
example, transgenic mice that express human apolipoprotein B-100, resulting in
increased VLDL and LDL plasma concentrations, will have atherosclerosis development
largely consisting of macrophage foam cells when fed high-fat diets [53]. Other
genetically engineered mice include those deficient for the LDL receptor, which form
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fatty streak lesions when fed a high-fat diet progressing to a necrotic core, but without a
fibrous cap [54]. Serum cholesterol levels can reach 1500 mg/dl with the majority
composed of LDL and IDL in these mice [55]. In these knockout mice, the earliest
lesions appear in the vicinity of the aortic valves. Soon after, other sites with high
predilection are affected: the small curvature of the arch; the orifices of the
brachiocephalic, left subclavian, and common carotid arteries; the branch sites of the
mesenteric and renal arteries; and the iliac bifurcation. The lesions formed at these loci
then grow toward the lumen and expand laterally. The speed at which these various
knockout mice develop plaques, though, is often too rapid for the determination of the
effects of a potential confounding factor.
Of the inbred strains, C57BL/6J mice develop fatty streak lesions consisting of
several layers of foam cells in the subendothelial space of their aortas when fed diets
consisting of 1.25% cholesterol, 0.5% cholic acid, and 15% fat for several months [56,
57]. Such a diet increases their cholesterol levels two to three-fold (200-300 mg/dl), the
majority of which is contained in non-HDL fractions [55]. However, the
hypercholesterolemia alone is insufficient to induce significant atherogenesis. The
addition of cholic acid to the diet enhances inflammation, and allows the accumulation of
macrophages in the aortic intima [47]. As with the transgenic mice, the lesions are first
formed under the aortic valve leaflets where tllrbulent flow is prevalent. Paigen and
coworkers have shown that these mice will have 4,500-8,000 f.lm2 aortic lesions at 14
weeks, most of which occur at the junction of the aorta and the heart [57]. At nine
months, the lesions can encompass 8% of the aortic length. Furthermore, it has been
15
demonstrated that female C57BU6J mice will produce larger atherosclerotic lesions than
males [58].
All of the experimental mice described, however, will develop lesions in the same
inflammatory-fibroproliferative manner as humans [59]. Furthermore, the lesions can be
easily dissected and studied both histomorphometrically and with electron microscopy
[57]. Thus, because inbred C57BL/6J female mice will not form atherosclerosis at a rate
and severity as extensive as other genetically engineered mice, possibly masking the
effect of experimentally introduced mediators, they make an excellent model for the
development of atherosclerosis in this study.
The epidemiological association between periodontitis and atherosclerosis
Because both chronic periodontitis and atherosclerosis possess similar pathogenic
processes as described above, many studies have attempted to find a cause-effect
relationship between the two conditions. To date, there are only eight longitudinal studies
published describing the effect of periodontal disease prevention or treatment on
cardiovascular events [60-67]. Six of the eight suggest that the presence of periodontal
disease precedes cardiovascular events, while two found no such relationship. All of the
studies vary with regard to patient population, classification of periodontal disease,
cardiovascular olltcome examined, and adjustments for potential confounders. Because of
these differences, comparisons among the studies are limited.
Beck and co-workers [63] analyzed data for 1,147 men from the Normative Aging
Study and the Dental Longitudinal Study of the Department of Veterans Affairs. Mean
16
bone loss and periodontal probing pocket depths were recorded per tooth at baseline and
follow-up examinations up to 18 years later. Two hllndred seven of the originally healthy
patients developed CAD, and forty others succumbed to stroke. After adjusting for age
and other cardiovascular risk factors, the odds ratios associated with having at least 20%
mean alveolar bone loss were 1.5 for CAD and 2.8 for stroke. Another study by Joshipura
et al. [62] followed 44,119 healthy male health care professionals at baseline for 6 years.
The authors noted 757 new cases of CAD. A positive correlation for tooth loss due to
periodontal disease and CAD was determined with a relative risk of 1.67 after adjusting
for standard CAD risk factors. It must be noted, however, that periodontal disease in this
population was self-reported as a dichotomous variable, which does not allow for
quantification of extent of periodontal disease.
The study conducted by Hujoel and colleagues [65] examined data collected from
the first National Health and Nutrition Survey (NHANES I: 1971-1975) with its 21-year
follow-up findings. They measured the association between periodontitis as determined
by the Russell Periodontal Index with death or hospitalization due to CAD. After
adjusting for confounding factors, no association was found for gingivitis, and an odds
ratio of only 1.14 was calculated for periodontitis. It is interesting to note that the earlier
study by DeStefano et al. [60] used the same NHANES I database with 15 years of
follow-up using the same periodontal index and found a statistically significant
association between the two diseases with a relative risk of 1.72. It has been postulated
that the discrepancy between the two studies is because Hujoel and co-workers either
overadjusted for confounding factors which may have been associated with periodontal
disease, or misclassified the periodontal status of patients at baseline [68].
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Thus, there seems to be some evidence, not necessarily of a cause-effect
relationship, but of a moderate correlation between periodontal disease and
cardiovascular disease. There are several proposed systemic mediators linking the two
diseases: direct bacterial infection, pro-inflammatory cytokines, acute-phase plasma
proteins such as C-reactive protein (eRP) and serum amyloid A (SAA), and fibrinogen
[69]. The monocyte-derived cytokines such as IL-l, IL-6, IL-8, and TNF-a can induce
atherosclerosis by enabling hepatic production of fibrinogen and CRP, which activate
complement and cause platelet aggregation. These cytokines also have the potential to
increase the expression of cellular adhesion molecules at the vascular endothelium,
thereby attracting more monocytes to the intima. Thus, periodontal infection, consisting
of a reservoir of specific Gram-negative microorganisms, has the potential to stimulate
the cytokine storm either at the inflamed periodontal tissues or in the systemic
circulation.
Indirect experimental evidence supports the possibility of direct invasion of major
arterial walls by specific periodontal pathogens, particularly P. gingiva/is [70, 71]. PCR
detection of genomic markers for periodontal pathogens indicates that only a small
percentage of carotid atheromas are contaminated with P. gingiva/is, although almost half
of human carotid atheromas are positive for the major periodontal pathogens. However,
histological verification of artery invasion by periodontal pathogens has not been
demonstrated in humans in situ. Assuming that periodontal disease in adults predisposes
individuals to cardiovascular disease, it appears that either the microbial flora gains entry
into the systemic circulation and prompts a more rapid progression of atherosclerosis, or
the local inflammatory events associated with periodontal disease spillover into the
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systemic circulation to the extent that atherosclerosis progression is accelerated. In fact,
both events may be involved in the promotion of atherosclerosis in subjects with
periodontal disease.
Recent evidence by Varlamos [72] and Nichols (unpublished data) has shown that
the same phosphorylated dihydroceramides recovered from P. gingivalis are also
recovered in lipid extracts of carotid endarterectomies from patients with periodontitis.
The carotid atheromas were consistently contaminated with bacterial lipids most likely
derived from P. gingivalis or other phylogenetically-related organisms, as determined by
the recovery of 3-0H iSOC17 :0 0r isobranched 19-carbon long-chain bases. If P. gingivalis
lipids containing 3-0H iSOC17:0 can contaminate the periodontal tissues [24], local host
monocytes and macrophages could incorporate them into their membranes, re-enter the
systemic circulation, and transport them to arterial endothelia susceptible to
atherosclerosis. Conversely, if P. gingivalis gains entry to the systemic circulation during
frequent bacteremias associated with oral hygiene measures or oral function, circulating
phagocytic cells can clear the microorganism, but will ultimately become contaminated
with the bacterial lipids which are likely difficult to break down. Since evidence has
demonstrated that the bacterial lipids of P. gingivalis are potent activators of
proinflammatory events in fibroblasts and peripheral blood monocytes [29], an increased
source of inflammatory mediators may be available for the initiation and possible
accelerated formation of atherosclerosis.
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OBJECTIVE
The purpose of this investigation is to determine whether bacterial ceramides
from P. gingiva/is, when injected into the peritoneum, can induce and/or accelerate the
formation of atherosclerosis in C57BL/6J female mice fed either normal or high-fat diets.
The total lipid recovered from P. gingiva/is and two biologically active HPLC lipid
fractions will be tested. The biological activity of lipid fractions was previously
determined by showing elevated prostaglandin secretion from cultured human gingival
fibroblasts in response to IL-I r291. All test mice injected with bacterial lipid, regardless
of diet, will be compared to control mice without any intra-peritoneal introduction of
bacterial lipid. After following the mice for several months on their respective diets, the
animals will be sacrificed, and their hearts and aortas removed. Histological cross-
sections of the proximal aortas will be stained and examined by light microscopy for
extent and severity of atherosclerosis formation. The percent of the aortic wall stained for
lipid deposits will be compared among the groups. Additionally, bacterial lipid recovery
from the descending aortas will be analyzed using previously described GC-MS methods
[24].
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MATERIALS AND METHODS
Lipid extraction from P. gingivalis
Porphyromonas gingivalis, obtained from ATCC (#33277, type strain), was
cultured in an anaerobic chamber as previously described [24]. Extraction of the lipid
from P. gingivalis was performed according to a Garbus modification [73] of a
standardized procedure as described by Bligh and Dyer [74]. A methanol-chloroform
solution and water (2: 1, vol/vol) was added to the bacterial sample for extraction and
allowed to stand overnight. Following this, chloroform (CHCI3) and 2M KCI + 0.5M
K2HP04 were added to the sample and vortexed. The lower lipid phase was removed,
dried u.nder nitrogen, and after redissolving the lipid extract in chloroform, a small
sample was dried and weighed on a microbalance scale. The total lipid extract was then
stored at -20°C until further use.
Lipid fractionation by HPLC
Fractionation of the bacterial lipids by high-performance liquid chromatography
(HPLC) was accomplished using a direct phase semipreparative silica gel column (0.5 x
30 cm; silica gel, Supelco Inc.) as previously described [24]. Lipid samples were
dissolved in solvent A (hexane-isopropanol-water, 6:8:0.75, vol/vol/vol) to a
concentration of 250 mg/5 ITll. Approximately 500 Jll of the lipid sample was then applied
to the column and samples were eluted at 2 ml/min with 1 min fractions collected. The
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fractions were then dried under nitrogen and suspended in 2 ml of chloroform. Lipid
recovery was determined by weighing a defined amount of each fraction (generally 5 J..LI
dried onto a weighing boat) on a microbalance scale.
Determination of biological activity with human gingival fibroblasts
Primary cultures of human gingival fibroblasts (HGF) previously obtained at the
University of Connecticut Health Center Periodontology Clinic dllring periodontal
surgery from healthy sites were used for evaluation of biological activity of the P.
gingivalis lipid fractions [29]. All cell culturing was performed by the techniques
described by Richards and Rutherford [75]. The fibroblasts were cultured in Minimum
Essential Medium (MEM) supplemented with 10% fetal calf serum, amphotericin B (1.25
J..Lg/ml), penicillin G .(500 D/ml), and streptomycin (500 J..Lg/ml) in a water-saturated, 50/0
CO2 atmosphere at 37°C. For all passaging of cells, fibroblasts were diluted
approximately 1:4 with each passage. Cells were harvested using trypsin (0.1 %, w/vol) in
Ca2+JMg2+-free phosphate-buffered saline (PBS) and resuspended in MEM for passaging.
Predetermined amounts of selected HPLC lipid fractions were dissolved in
CHCI3, transferred to clean conical vials, and dried under nitrogen gas. Since the bacterial
lipids showed little solubility in aqueous solvent, the selected fractions were dissolved in
ethanol to a 1 mg/ml concentration. Ten J..LI of each lipid sample was then placed into a 35
mm diameter culture well under a laminar flow hood. Vehicle wells received ethanol
only. The ethanol was allowed to evaporate overnight leaving a residue of lipid on the
well surface.
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The cultured fibroblasts were then inoculated into the culture wells at the same
cell nUlTlber:sllrface area ratio as was achieved in the culture flasks with cells at
confluence. Following inoculation, the fibroblasts were allowed to adhere for 2 hours
after which the medium was supplemented with either control medium or medium
containing recombinant human IL-l ~ to a final concentration of lOng/mI. After the cells
were incubated for another 24 hours, they were examined by light microscopy and
photographed.
Prostaglandin recovery in medium samples was determined using stable isotope
dilution with deuterated prostaglandin standards. PGF2a, 6-keto PGF1a, and PGE2 were
quantified in medium samples using a modification of the method of Luderer et ale [76],
previously described by Nichols [24]. Each medium sample was supplemented with 100
ng of D4- PGF2a, D4-6-keto PGF1a, and D4- PGE2. The fibroblast medium samples were
then thawed and the pH adjusted to 3.5 with concentrated formic acid. The acidified
medium samples were then applied to reverse phase preparative columns (Supelcoclean,
C-18 SPE tubes, 6 lTtl, Supelco Inc., Bellefonte, PA) mounted on a vacuum manifold.
Before applying the medium samples, the C-18 colunlns (3 ml) were regenerated by
running sequentially 3 ml of 100% methanol followed by 3 ml of Ca2+JMg2+-free PBS
(pH 3.5). Each acidified medium sample was then applied to individual C-18 columns,
the columns were washed with 3 ml of 25% methanol in water, and enriched
prostaglandins were eluted with 3 ml of 100% methanol. The resultant samples were then
supplemented with 2 rnl of 1% formic acid in water and the prostaglandins were extracted
twice with 2 rnl of chloroform. The chloroform extracts were dried under nitrogen.
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All derivatizing agents were obtained from Pierce Chemical Corp. (Rockford,
IIJ.). Prostaglandin samples were derivatized using the method of Waddell et al. [77].
Briefly, prostaglandin samples were first treated with 30 J.lI of 2% methoxylamine
hydrochloride in pyridine. After standing overnight at room temperature, the samples
were dried under nitrogen, dissolved in 30 JlI acetonitrile, and treated with both 10 JlI
pentafluorobenzyl bromide (35% vol/vol in acetonitrile) and 10 JlI
diisopropylethylamine. The samples were then vortexed, incubated for 20 minutes at
40°C, and evaporated under nitrogen.
Ceramide analysis by GC-MS
Verification of the presence of the biologically active ceramides [29] in the HPLC
lipid fractions was accomplished using gas chromatography-mass spectrometry (GC-MS)
analysis according to the method proposed by Nichols [241. All analyses were performed
on a Hewlett Packard 5890 gas chromatograph interfaced with a 5988A mass
spectrometer. The P. gingivalis fatty acid samples were treated with 50 JlI N,O-bis
(trimethylsilyl)-trifluoroacetamide (BSTFA) for 4-5 days at room temperature to form
trimethylsilyl (TMS) derivatives; and each sample was transferred to a microvial and
sealed with a Teflon-lined crimp cap. Each sample was then run on a SBP-l column (0.1
mm film x 0.25 mm x 15 nl) with the inlet block at 310°C using the splitless mode with a
tenlperature program of 10°C/min fronl 200°C to 300°C followed by 5°C/min to 310°C
and 4 min at 31 ODC. An electron impact ionization mode was used for the mass
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spectrometer with the ion source temperature at 200°C, electron energy at 70 eV, and
emission current at 300 mAe
Pooling and purification of biologically active HPLC lipid fractions
HPLC lipid fractions 15-20 and 31-34 were dissolved in 4 ml chlorofoffi1
sequentially and combined. The pooled fractions were refractionated using HPLC as
described above on the same semi-preparative silica gel column (0.5 x 30 cm; silica gel)
and eluted in solvent A at 2 ml/min with 1 minute fractions collected. An aliquot from
each fraction was dissolved in BSTFA and the solutions were allowed to stand for 1 hour
at 60°C. After drying each fraction under nitrogen gas, a small amount of each fraction
was evaluated to verify ceramide content using positive-ion GC-MS on a SBP-l column
(0.1 mm film x 0.25 mm x 15 m) as described above.
Animal experiments
A total of 40 fOllr-week old C57BU6J female mice (# 000664, Jackson
Laboratory) were used in the present investigation and separated into eight different
groups of five mice each. Twenty mice (a contingency of four groups) were fed a normal
diet (LM-485, Harlan Teklad); and the remaining twenty mice (a second contingency of
fOllr groups) were fed a high-fat diet (TD 94059, Harlan Teklad) for the entirety of the
experiment. This diet, a modification of the Paigen diet [57] by excluding cholic acid,
consists of about 4 kcallg, and contains 1.25% cholesterol and approximately 15% fat.
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Cholic acid is normally added to the high fat diet to increase systemic inflammation and
accelerate fatty deposition in artery walls. This supplement was removed from the mouse
chow so that systemic inflammatory changes were minimized. After a few days of
acclimation, each group of the normal diet contingency and each group of the high-fat
diet contingency received one of the following via intraperitoneal (i.p.) injection:
1. Fraction 17 (10 JlI, 1 Jlg/JlI in 100% ethanol) of the previously characterized,
biologically-active ceramide HPLC lipid fractions recovered from P. gingivalis.
2. Fraction 28 (25 IJ,1, 0.4 Jlg/1J,1 in 70% ethanol) of the previously characterized,
biologically-active ceramide HPLC lipid fractions recovered from .P. gingivalis.
3. Total lipid (10 JlI, 1 Jlg/JlI in 100% ethanol) recovered from P. gingivalis.
4. Vehicle control (10 JlI 70% ethanol).
Each animal was injected once with its respective solution using a Valco precision
sampling syringe (Series C-160, Supelco Inc., Bellefonte, PA), and monitored for
changes in activity. Within the first few days after injections, 18 mice died, most of
which were in the bacterial lipid groups. Since a significant percentage died so early in
the experiment, it was decided to modify the protocol and include additional mice
injected with a smaller dose (2.5 Jlg) of the fraction 28 lipid and the total lipid extract
from P. gingivalis. Twenty additional female C57BL/6J mice were separated into two
contingencies of ten mice each depending on their diet. Each contingency was divided
into two groups of five mice each and the following was injected once into the
peritoneum per group:
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1. Fraction 28 (2.5 J..lI, 0.1 J..lg/J..lI in 100% ethanol) of the previously characterized,
biologically-active ceramide HPLC lipid fractions recovered from P. gingivalis.
2. Total lipid (2.5 J..lI, 2.5 J..lg/J..lI in 100% ethanol) recovered from P. gingivalis.
The mice were housed in cages separated according to group and diet. All
experimental methods were approved by both the Center for Laboratory Animal Care
(CLAC), and the Animal Care Con1mittee (ACC) at the University of Connecticut Health
Center. Furthermore, all animal treatment was performed in a humane manner. The cages
were maintained daily for adequate food, water, and bedding by the CLAC staff. The
mice were monitored daily for the first two weeks, and then weekly for the remainder of
the experiment by the primary investigator for changes in activity, movement, and
possible death.
Animal sacrifice, tissue preparation, and staining
The mice were sacrificed after 12-13 weeks on their respective diets. After
weighing, each mouse was placed in a closed chamber, anesthetized, and killed by
inhalation of carbon dioxide. Immediately after death, dissection and fixation of the
appropriate tissues was performed. After opening the chest and abdomen, the heart and
aortic tree were exposed and identified. The descending aorta was then cut at the level of
the kidneys. Next, the heart and aortic tree were perfused using a 25-gauge needle with
Ca2+JMg2+-free PBS (pH 7.4) until no blood was noted exiting the aorta. Immediately
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after perfusion, the descending aortas were cut at the level of the aortic arch, removed,
and frozen for further analysis. Next, the hearts were removed from the body, oriented,
and cut about halfway through their length at a plane parallel to the tips of the atria with
tissue scissors as described by Paigen et al. [57]. This plane allowed for proper
orientation of the aortic sinus for cryostat sectioning. The hearts were fixed in 10%
formalin and stored overnight in preparation for embedding and freezing.
Following fixation, each heart specimen was examined under a dissecting
microscope for proper orientation, and extraneous tissue carefully removed. If needed,
adjustments to the orientation of the plane were made at this time with a sharp razor
blade. Each heart was then embedded in 16 x 12 x 5 mm blocks containing Tissue
Freezing Medium (Triangle Biomedical Sciences), immediately frozen in isopentane
cooled on dry ice, and stored at -40°C for further use. Microtomy was performed using a
Reichert HistoStat cryostat microtome. In detail, each block was frozen on a cryostat
mount with Tissue 'Freezing Medium, trimmed, and sectioned starting with the mOSt
apical portion of the heart. Sequential 10 Jlm sections were made until the three aortic
valve leaflets were located. Once this area was found, serial sections were cut and
mOllnted on Superfrost Plus microscope slides (Fisher Scientific) until the aorta assumed
a round shape Gust beyond the branch points of the coronary arteries). Since this distance
is approximately 280 l1.m [57], a maximum of about 28 sections per heart were saved.
The sections were then stained as described by Humason [78]. Briefly, slides were
rinsed in distilled water and washed in 100% propylene glycol for 5 minlltes. Next, they
were stained with filtered Oil red 0 (0.5 g/100 ml propylene glycol) for 15 minlltes, and
washed in 85% propylene glycol for 5 minutes. After rinsing in several changes of
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distilled water, the slides were counterstained with 0.1 % Mayer's hematoxylin (Sigma)
for 8 minutes. Finally, they were rinsed again in several changes of distilled water and
immediately cover-slipped using glycerin-gelatin mounting medium. All slides were
allowed to dry overnight.
ouantification of atherosclerotic lesions
All sections were examined on a Leitz Orthoplan light microscope at 4x
magnification and photographed with a Nikon CoolPix 5000 digital camera (2560 x 1920
pixels) using a calibrated lens setting. Four sections from each aorta were then used for
morphometric evaluation as previously described [79]. Those sections chosen for analysis
were from the following aortic regions: the aortic valve leaflets seen in their entirety, the
valve attachment sites near the coronary ostia, the valve attachment sites visible as small
nodules, and the proximal aorta characterized by its round cross section. Lesion sizes at
each of the four sites were quantified, and a mean was calculated to represent the
percentage of atherosclerosis formation for each mouse. If aortic regions were not
available in some specimens due to sectioning or staining error, no substitutions with
other sections were permitted. The extent of atherosclerosis was quantified by computer-
assisted image analysis using Adobe Photoshop software. Specifically, the percentage of
stained lesion area in the entire vessel wall was calculated by dividing the number of red
pixels (of a defined threshold range) by the total number of pixels in the aortic wall.
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Lipid recovery from descending aortas
Bacterial lipid extraction of the unfixed descending aorta specimens was
performed using a chloroform-methanol solution with water (2: 1, vol/vol) as described
above. After allowing the specimens to stand for several days in extraction solution,
CHCl3 and 2M KCI + 0.5M K2HP04 were added to the samples and vortexed. The lower
lipid phase was separated and dried under nitrogen. The lipid extracts were then
supplemented with 3 Jig of C19:0 internal standard, and hydrolyzed for 2 hours in 4N
KOH at 1aooe. The samples were then acidified (200 ~ll of concentrated HeI) and
extracted with chloroform (3 x 2 ml). The extracted lipids were dried under nitrogen and
treated to form pentafluorobenzyl ester, TMS ether derivatives. Samples were dissolved
in 30 JJ,1 acetonitrile to which 10 Jil of 35% pentafluorobenzyl bromide in acetonitrile and
10 JJ,1 of diisopropylethylamine were added. The samples were vortexed and incubated at
40°C for 20 minutes. After drying the samples under nitrogen, each sample was treated
with 40 Jil of BSTFA and incubated overnight. Samples were then analyzed using
electron-capture negative chemical ionization GC-MS for recovery of 3-0H iSOC17 :0 as
previously described [24].
Statistical analysis
The stained aortic regions were analyzed by using analysis of variance (ANOVA),
comparing injected solution with animal diet (normal chow vs. high-fat chow). In
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addition, a similar analysis was performed for the recovered 3-0H iSOC17:0 profiles. All
analyses were performed using a computer software package (StatView).
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RESULTS
Immediately following the intraperitoneal injections, the majority of the mice
experienced limited mobility. After the first week, a few continued to exhibit slow
movement, but resumed normal locomotion soon thereafter. However, after three days,
12 deaths had occurred, and an additional six by the end of the first week. Of those 18
mice, the following number died per group: 8 of the total lipid group, 2 of the HPLC
fraction 17 group, 6 of the HPLC fraction 28 group, and 2 of the vehicle control group.
No other mice succumbed following the initial week. Since 45% of the experimental
mice died, including all of those in the total lipid group on the high-fat diet, twenty more
female C57BL/6J mice were added to the experiment. These were only injected with
fraction 28 and the total lipid extract, but with one-fourth the concentration of the initial
dosage. Just as with the higher dose, most of the mice experienced decreased mobility
immediately after i.p. introduction of the lipid solution. Within the first three days after
injections with this lower dose, three mice died. At the end of the first week, a total of 6
mice had died, all in the total lipid groups, regardless of diet. None died in the fraction 28
groups. All of the mice that died appeared weak, lethargic, and exhibited compromised
mobility. The remaining mice recovered and seemed active for the remainder of the
experiment. All deaths per group are shown in Figure 1.
Figure 2 illustrates the mean body weights of all groups prior to sacrifice. The
average weight of the 4-week old female C57BL/6J mice at the start of the experiment
was 14.3 g. After 12-13 weeks, the mean weight was 21.0 g for the mice fed the normal
diet, and 26.7 g for those fed the high-fat diet. This represents a 46.9% and 86.7%
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increase in total body weight, respectively. The 5.7 g (27.1 %) difference between the two
diet groups was statistically significant (P < 0.001). Two-way ANOVA showed no
significant difference in weight between any of the lipid treatments and the vehicle
control, regardless of diet group. Furthermore, there were no statistically significant
differences between the lipid treatments on mouse body weight for either diet group (P <
0.01).
In the cross-sectional histomorphometric analysis of atheroma lesions, two aortas
in the high-fat diet contingency were discarded due to technical errors: one in the vehicle
control group, and the other in the fraction 17 group. All four representatives of the
required artery sections were located in 25% of the aortas. Three sections were used in
50% of the aortas; and one or two sections in the remaining 25% of the aortas analyzed.
Figures 3 and 4 illustrate the steps taken for analysis with all four section representatives
in one of the aortas from a mouse injected with 2.5 J..lg of the total lipid extract and fed
normal chow. Figure 3 shows the original micrographs of the four representative sections
at 4x magnification. Stained adipose tissue is noticeable in the tissues surrounding the
aortic cross-sections. Figure 4 shows one of the sections digitally outlined, including a
higher magnification of a portion of that section with bright red digitally added to all
areas of lipid stain within the arterial wall (Panel D). Highlighting the stained areas (seen
in Panel C) one particular color facilitated determination of the exact number of pixels for
the analysis.
The percent lipid deposition in the arterial wall per group (as determined by pixel
counts), is shown in Figure 5. The extent of atherosclerosis in all of the mice was
primarily type I and II lesions, namely foam cell and fatty streak formation. In none of
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the sections were well-defined acellular lipid cores noticeable. One-way ANOVA
showed no difference between diet groups and amount of lipid deposition. However,
there was a significant (P < 0.0001) difference between bacterial lipid treatments and
aortic lipid deposition, regardless of diet. All high-dose lipid treatments were
significantly (P < 0.001) increased compared to the vehicle control. In fact, a 4.5-fold
increase in aortic lipid deposition was noted for all 10 J..Lg lipid groups compared to the
vehicle control. For the lower lipid dose (2.5 J..Lg), though, only the total lipid extract
group had significantly (P < 0.001) more lipid deposits than the vehicle control. Here,
when compared with vehicle controls, the amount of lipid stain was doubled for the 2.5
J..Lg fraction 28 group; and was tripled for the 2.5 J..Lg total lipid extract group.
When comparing each treatment group, the mice injected with the higher lipid
doses had significantly (P < 0.001) more aortic lipid deposits than those injected with the
lower doses. In the 10 J..Lg dose, there was no significant difference between fraction 28
and the total lipid extract for aortic lipid deposition, btlt fraction 17 had significantly (P <
0.001) fewer deposits than both fraction 28 and the total lipid extract. For the 2.5 J..Lg
dose, there was no statistically significant difference between fraction 28 and the total
lipid extract.
For mice fed the normal chow, there was a statistically significant (P < 0.001)
increase in aortic lipid deposition among all bacterial lipid treatments compared to the
vehicle control for the larger lipid dosage. For mice injected with the lower (2.5 J..Lg) lipid
dosage, only the total lipid extract showed significantly more deposition than the vehicle
control. The mice injected with the higher bacterial lipid doses had significantly (P <
0.0001) more deposits than those injected with the lower doses. For mice injected with 10
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J..Lg of lipid, there were no statistically significant differences between fractions 17 and 28,
and fraction 28 and the total lipid extract. However, there was a significant difference (P
< 0.001) between fraction 17 and the total lipid extract. In the 2.5 J..Lg dose groups, no
difference was noted between fraction 28 and the total lipid extract.
For mice fed the high-fat diet, there was a statistically significant (P < 0.0001)
increase in aortic lipid deposition among all lipid treatments compared to the vehicle
control, regardless of bacterial lipid dosage. The mice injected with the higher lipid doses
had significantly (P < 0.001) more deposits than those injected with the lower doses. For
mice injected with 10 J..Lg of lipid, fraction 28 showed significantly (P < 0.001) more lipid
deposition than fraction 17. In the 2.5 J..Lg dose groups, the total lipid extract was
significantly (P < 0.001) greater than fraction 28 lipid.
The descending aortas were analyzed by GC-MS for 3-0H C14:0, 3-0H C16:0, and
3-0H iSOC17:0 content using a 3-0H C19:0 internal standard. Only data for 3-0H iSOC17:0
are shown in Figure 6. There was no statistically significant difference between the two
diet groups for recovery of 3-0H iSOC17 :0 o For the groups injected with 10 J..Lg of lipid,
there was a trend of increased 3-0H iSOC17:0 recovery for mice fed high-fat diets;
however, in mice on the normal chow, only the total lipid group showed a higher 3-0H
iSOC17 :0 abundance compared to the other treatment groups. None of these differences
were significant using two-way ANOVA. In the mice injected with 2.5 J..Lg of lipid, the 3-
OR iSOC17:0 recovery decreased from fraction 28 to the total lipid extract in both diet
contingencies, although this was also not statistically significant.
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DISCUSSION
Central to the findings of this study are the nature of specific lipids which were
administered. As stated previously, more than 50% of the hydroxy fatty acid content of P.
gingiva/is is 3-0H iSOC17 :0, none of which is known to be produced by mammalian
species. Previous studies have recovered ceramides of unknown structures containing 3-
OH iSOC17:0 from diseased human gingival tissues, cementum, and carotid
endarterectomies [27,72]. Furthermore, only the Bacteroides species found in humans
are capable of producing such lipids. Since several of these species have been associated
with periodontal attachment loss, the recovery of 3-0H iSOC17:0 within human vascular
tissues suggests the possibility that periodontal infection may contribute to cardiovascular
diseases such as atherosclerosis, ischemic heart disease, myocardial infarction, and
stroke.
Mass spectrometry and nuclear magnetic resonance have elucidated the structures
of the two complex ceramide HPLC lipid fractions used in this study [28]. Fraction 17
lipids (Figure 7) have three aliphatic constituents: an isoC15 :ochain that is ester-linked to
the ~ carbon of the 3-0H iSOC17:0 ; and either iSOC17:0 , C18:0, or iSOC19:0 long-chain bases
in amide linkage to the 3-0H iSOC17:0• Attached to the first carbon of the long-chain bases
is a phosphoglycerol head group with a total lipid mass of 933, 947, or 961 amu, as
detected by electrospray MS analysis. Loss of the phosphorylated head group of fraction
17 lipids occurs from thermal decomposition associated with the injection block exposure
under GC-MS analysis. This results in loss of the iSOC15:0 chain, desaturation of the
proximal end of the long-chain base, and formation of McLafferty ions, creating
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structures with long-chain bases in imine linkage to 3-0H iSOC17 :0 with masses of 577,
591, or 605 amu.
Fraction 28 lipids (Figure 8) have three long-chain bases in amide linkage to 3-
OH iSOC17 :0• As with fraction 17 lipids, one aliphatic chain represents 3-0H iSOC17 :0
while the others are either iSOC17:0, C18:0, or iSOC19:0 long-chain bases. When the
phosphoethanolamine head group is attached to the first carbon of the long-chain base,
the mass of this ceramide lipid is 678, 692, or 706 amu. Under GC-MS analysis
conditions, fraction 28 lipids also undergo thermal decomposition with loss of the
phosphorylated head group that produces structures with masses of 667, 681 and 695
amu.
The concept of infection as a cause of atherosclerosis is not new to cardiovascular
pathology. Thus far, researchers have suggested Chlamydia pneumoniae [80],
Helicobacter pylori [81], and cytomegalovirus [82] as possible infectious links between
systemic infection and cardiovascular disease. Of these, the largest body of evidence
supports infection with C. pneumonia, which has been detected in up to 80% of
atherosclerotic vessels [83]. Furthermore, viable C. pneumonia has been recovered from
38.5% of aortic aneurysms in another study [84]. Although H. pylori and
cytomegalovirus have been discovered in atheromatous vessels by DNA analyses, their
association is much weaker [85]. Most recently, periodontal pathogens such as P.
gingivalis, P. intermedia, T. forsythensis, and A. actinomycetemcomitans, have been
recovered from 44% of atheromas by PCR analysis of 16s ribosomal DNA [86].
Several mechanisms have been proposed for the role of infection as a causative
agent of cardiovascular diseases, especially atherosclerosis. The evidence accumulated
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thus far suggests the possibility that microorganisms can directly invade vascular
endothelial cells, initiating a local inflammatory response. With the frequent bacteremias
associated in patients with periodontitis, it is certainly possible for specific pathogens
such as P. gingivalis to attach to vascular endothelium just as they would the junctional
or sulcular epithelial cells in a periodontal pocket. In fact, researchers have found in vitro
evidence of P. gingivalis invasion of both bovine aortic endothelial cells [70] and, more
recently, human carotid and coronary endothelium [87]. Second, microorganisms may
enhance atherogenesis by recruiting host inflammatory cells, stimulating pro-
inflammatory cytokines production by the endothelial cells, or upregulating macrophage
oxLDL receptors. Third, inflammatory cytokines produced from local sources, such as
the periodontal pocket, may enter the systemic circulation, finding their way to vascular
walls.
Assuming this potential of bacterial infection as a contributing agent for
atherosclerosis, Li and colleagues [88] intravenously inoculated heterozygous ApoE
deficient and wild-type C57BL/6 mice with live P. gingivalis weekly for 10, 14, or 24
weeks. Both cross-sectional and en-face quantification of aortic atheroma formation
showed a statistically significant 7-fold increase of lesion area in the transgenic mice at
14 weeks on a normal diet compared to controls on normal chow. The wild-type mice
only had early foam cell lesions after 24 weeks when fed a high-fat diet. Furthermore, P.
gingivalis 16s ribosomal DNA was found only after 24 weeks in all samples injected with
the bacterium. Lalla and coworkers [89] applied P. gingivalis topically in the oral cavity
of homozygous ApoE deficient mice over a 3-week period. After 17 weeks, the hearts
and proximal aortas of the ApoE-1- mice showed a statistically significant 40% increase in
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mean atherosclerotic lesion area compared to controls. Interestingly, PCR analysis of the
vessel walls showed that only 2 of 9 infected mice were positive for P. gingivalis DNA,
suggesting that although it may be possible for these microorganisms to invade
endothelial cells, it may not be an absolute requirement in order to elicit an inflammatory
response. Thus, the entire P. gingivalis organism is certainly capable of accelerating
atherosclerosis formation in ApoE deficient mice, but it is unclear as to what portion of
the bacterium stimulates the inflammatory response.
A fourth proposed mechanism focuses on the specific bacterial lipids used in this
experiment. If periodontal pathogens like P. gingivalis can readily attach to the epithelial
cells in a periodontal pocket [33] or invade the underlying connective tissue [34], they
could introduce their cell wall components, some of which contain 3-0H iSOC17:0, to host
inflammatory cells such as monocytes and macrophages [24]. With the evidence
suggesting that P. gingivalis releases outer membrane vesicles in culture medium [30], it
is certainly plausible that other cells local to the inflamed gingival connective tissue may
incorporate these vesicles into their own membranes. These cells might then re-enter the
circulation carrying these biologically active lipids in their cell membranes to other sites
including arterial walls. As the monocytes enter the intima, the bacterial lipid can
enhance the inflammatory response, thus accelerating the atherogenic process. It is this
nlechanism that is the basis of this study.
The finding that 15 mice died within the first three days after injection, and 9
more by the end of the first week is significant. Those that died appeared weak with
limited movement during that time period, but none had skin lesions at the site of
injection. The deaths of two mice in the control group on the high-fat diet are most likely
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due to technical error in the injection sequence. This group was injected after the total
lipid group on the normal diet. Although the injection syringe was flushed several times
with 100% ethanol in between groups, there may have been some residual lipid
contamination of the syringe which was introduced into these mice. The highest
proportion of deaths per group was in the total lipid group (70%). Eighty percent died
after introduction of 10 IJ,g of lipid, and 60% died with the 2.5 IJ,g dose. Of the other
groups, only two died after injection with fraction 17, and six with fraction 28 (all of
which were with the higher dose). Since the animals died relatively soon after injection, it
is unlikely that the difference in diet influenced this finding.
It is unlikely that the i.p. use of ethanol as a solvent contributed to the animals'
death in this experiment. The mice in this experiment were injected with a single dose of
solution ranging from 0.000143 mg/kg to 0.00143 mg/kg. This proportion of alcohol is
much less than that used in previous reports which describe its toxicity and systemic
effects, and resulted in zero deaths when given via i.p. injection [90, 91]. One particular
study found a dose-dependent relationship between alcohol concentration by intravenous
injection and central nervous depression, but with intraperitoneal administration, the
depressant effect of ethanol increased with increasing concentration up to 70%, but
showed a significant reduction at 90% [92]. Thus, it appears probable that a 70-100%
ethanol concentration at low doses by i.p. injection would not induce respiratory
depression sufficient enough to kill mice, particularly 3 to 5 days later.
Unpublished necropsy reports 2-3 days after i.p. injection of four mice with 5 IJ,g
of P. gingivalis ceramide lipid in 5 JlI of ethanol showed peritonitis and transmural
necrotizing enteritis. Interestingly, half of these mice exhibited signs of hepatic necrosis.
40
Although it is possible that some of these biologically active lipids may have been
inadvertently injected into other abdominal organs, such a finding may also suggest that
they can be carried to other organ tissues in addition to the vasculature.
The Oil red 0 stain was chosen because of its popularity with other laboratories
describing atherosclerosis formation as determined by light microscopy. Like the Sudan
dyes, it is a general stain for lipids that exist as fat globules in cells and tissues. It will
only stain lipids that are liquid or semi-liquid at the staining temperature. Thus, those
lipids that are solid or crystalline remain unaffected. However, if the lipid is bound to
protein or carbohydrate, then even if it is a liquid or semi-liquid, it might not stain. Oil
red 0 can be used with either isopropanol or propylene glycol as a solvent; however,
some neutral lipid may be dissolved during the staining process.
In almost every stained section in this study, there were several areas of very
bright-red droplets of stain located at many sites throughout the arterial tissue. The
difficulty was determining the validity of these stained areas. At some sites, it was
unclear as to whether they were true positives for atheromatous lipid, or artifactual
findings. In many of the mice fed the high-fat diet, there was much more adipose tissue
around the target sections, which provided a larger source of unwanted extraneous stain
droplets in the arterial wall which could not be washed away effectively. Furthermore,
some sections stained and/or counterstained at different intensities than others. This made
the analysis for extent of atheroma formation challenging and provided a possible source
of error.
In order to deal with this problem, a protocol was devised for the analysis. The
amount of stain per section was determined by selecting all stained areas with a
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consistent point sample threshold for all analyzed sections. Red stains which were
obvious artifact (unusually large globules, globules impinging on vessel borders, etc.)
were excluded; those which were questionable were included in the analysis. Since some
sections were stained at different intensities, the manual selection (and de-selection) of
stain made the analysis much more precise than solely allowing the computer to select all
colors in a defined red range, by which some colors would be either included or excluded
from the analysis. Once this was completed, it was relatively easy to calculate the
percentage of each stained aortic area: the number of highlighted pixels (Panel D, Figure
4) in the entire aorta was divided by the total number of pixels of the entire outlined
section (Panel A, Figure 4).
The majority of the lesions noted in this experiment were stage I and II lesions.
Although much of the lipid deposition was found at the aortic valve cusps, many other
sections of the aortic sinus and proximal aorta had similar amounts of stain. A few
sections from mice fed the high-fat diet had lesions consisting of snlall pools of lipid
deposition. In none of the sections were well-defined borders found, walling off a
necrotic core of lipid and foam cells. None of the coronary arteries were occluded or had
significantly more intra-vascular lipid deposition that the aortas themselves. The 12-13
week duration of the experiment was probably not sufficient to induce true atheroma
formation in these nlice. The stage of atherosclerosis seen in this study is consistent with
other reports using similar C57BL/6J mice [56,57, 93, 94].
Although the finding that 10 Jlg of lipid had a significant (3-4-fold) increase in
lipid deposition is important, it is more interesting that the smaller 2.5 Jlg dose of total
lipid extract was associated with a significant increase in fatty streak formation. There
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was also a trend toward increased lipid deposition from fractions 17 and 28 to the total
lipid extract, although it was not always statistically significant. Since the total lipid
extract contains both fractions 17 and 28 (as well as other unreported biologically active
ceramides), this finding was not unexpected. Therefore, if all of the mice in the high-fat
diet total lipid group had not died, the intra-vascular lipid deposition would probably
have been the highest of all the groups.
For mice fed the normal chow, there were no significant differences between 10
Jlg injections of fractions 17 and 28, and between fraction 28 and the total lipid extract
for aortic lipid deposition. Fllrthermore, fraction 28 and the total lipid extract did not
differ significantly between diet groups. Such results suggest that i.p. administration of
these ceramide lipids to mice fed a normal diet has a similar effect with respect to fatty
streak formation as those fed a high-fat diet. In other words, P. gingivalis lipids appear to
accelerate the rate of atherosclerosis formation in C57BL/6J mice on normal diets. These
findings give additional credence to the hypotheses offered by Beck and coworkers [95]
and Nichols [24] for the concepts that periodontal inflammatory factors can have an
effect on other systemic inflammatory-mediated pathological processes.
After analyzing the abundance of 3-0H iSOC17:0 recovered from the descending
aortas, no statistically significant differences were noted among groups. The amount
recovered was extremely small compared to what is seen after 3-0H iSOC17:0 extraction
from whole cells of P. gingivalis. Furthermore, it is much less than the previously
reported abundances of the same fatty acid from human carotid endarterectomies [72],
although the relative size of the specimens may have accounted for some of the
difference. The paucity of 3-0H iSOC 17 :0 recovered from the aortas may suggest that these
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fatty acids may be found in other organ tissues such as the liver, gut, or brain, which is
consistent with the necropsy findings. It also suggests that only very small amounts of
these ceramides are required to exacerbate intra-vascular inflammatory pathology.
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CONCLUSION
Further studies are needed to elucidate this connection between periodontitis and
cardiovascular disease. Although it appears that specific bacterial ceramide lipids are as
pathogenic as the bacteria themselves, the two need to be compared in a single
experiment to confirm this hypothesis. Such a study would help to further understand the
overall mechanism of pathogenesis. Are peripheral blood monocytes transporting the
lipids to other tissues, or are the inflammatory mediators produced at diseased
periodontal tissues entering the systemic circulation and influencing vascular
pathogenesis? More mice per group, blood tests for inflammatory mediators, and tests
with LPS are needed to draw further conclusions. Additionally, introducing either LPS or
these biologically active bacterial lipids in C3H1HeJ mice, which are TLR-4 knockollt
mice, may further aid in the understanding of the mechanisms of action for both bacterial
toxins.
In conclusion, a single intraperitoneal injection of P. gingivalis ceramide lipids
facilitates increased lipid deposition in the proximal aortic arches of C57BL/6J female
mice. Although the two tested HPLC lipid fractions seem to exhibit equivalent responses
with respect to atherosclerosis formation, the total lipid extract appears to have a greater
influence than either of the two biologically active ceramides when compared to controls.
This could mean that fractions 17 and 28 act synergistically, or that other biologically
active lipids are present in P. gingivalis lipid extracts. Furthermore, the lipids can be
recovered from the aortas as evidenced by the recovery of 3-0H iSOC17 :0 from the
descending aortas. The minute amount recovered, however, suggests the possibility that
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these bacterial ceramides may be carried to other tissues. Finally, the early deaths of
nearly half of the n1ice illustrate the potency of these bacterial lipids, and the potential for
a systemic hyper-inflammatory condition.
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Section A
Section C
Section B
Section D
Figure 3. Representative aortic cross-sections (4x) from a mouse injected with 2.5 IJ,g of
the total lipid extract stained with Oil red 0 and counterstained with Mayer's
hematoxylin. Section A shows the aortic valve leaflets in their entirety. Section B shows
the valve attachment sites at the level of the coronary artery ostium. Section C shows the
valve attachment sites visible as small nodules. Section D shows the proximal aorta
characterized by its round cross section. Measure bars represent 500 IJ,m.
Panel A
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Panel B
Panel C Panel D
Figure 4. Higher magnifications of an aortic cross-section from a mouse injected with
2.5 Jlg of the total lipid extract illustrating the steps used for analysis. Panel A is a section
taken at the level of the aortic valves (4x), but is digitally outlined in black to facilitate
analysis. Scale bar represents 500 Jlm. Panels B, C, and D are digital zooms of the aortic
wall shown in the boxed portion of Panel A. Scale bars represent 50 Jlm. Panel B is from
the original micrograph stained with Oil red 0 and counterstained with Mayer's
hematoxylin. Both stained adipose tissue and unwashed red stain can be seen in the
surrounding connective tissue. Panel C shows the stained outlined wall. Panel D shows
the selected stains digitally highlighted in bright red.
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OH
~OH
M = 961,947, or 933 amu
(CH2 ) 3,2, or 1
*The I8-carbon long
* chain base is a straight
aliphatic chain rather
than isobranched
OH
Figure 7. Chemical structure of Porphyromonas gingiva/is HPLC lipid fraction 17
ceramides. The long-chain base in the middle is 3-0H iSOC17 :0• Sodium methoxide
treatment releases the I5-carbon isobranched methyl ester on the left. Two of the long-
chain bases are amide-linked with an attached phosphoglycerol head group.
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*The I8-carbon long
chain base is a straight
aliphatic chain rather
than isobranched
M = 706, 692 or 678 amu
*
~OH
H
\
N
Figure 8. Chemical structure of Porphyromonas gingivalis HPLC lipid fraction 28
ceramides. The long-chain base on the left is 3-0H iSOC17 :0 - The long-·chain bases are
amide-linked with an attached phosphoethanolamine head group.
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